Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update

By A. Bhatia, B. Burtness. 2023

Subfields: Immunology, Oncology, Otorhinolaryngology

Citations in the corpus

• Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas (2024, unknown): “However, tumor recurrence is common [4] with highly limited therapeutic approaches for this challenging clinical setting.”